FindTrial
Sign In

Clinical safety and efficacy study of Bachmann's bundle pacing

Clinical safety and efficacy study of Bachmann's bundle pacing

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102425
Enrollment
Unknown
Registered
2025-05-14
Start date
2025-05-20
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia

Interventions

Bachmann's Bundle Pacing Group:Implantation of the atrial lead in the Bachmann's bundle region
Right atrial appendage (RAA) pacing group:The atrial pacing lead is implanted in the right atrial appendage (RAA).

Sponsors

The First People's Hospital of Yunnan Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Patients with sick sinus syndrome or atrioventricular block, and indications for pacemaker implantation 2.Aged 18-80 years 3.Sinus rhythm

Exclusion criteria

Exclusion criteria: 1.Valvular heart disease requiring or having undergone surgical intervention 2.Atrial fibrillation (AF) 3.Atrial flutter (AFL) 4.History of acute myocardial infarction (AMI) within 3 months prior to enrollment 5.Life expectancy less than 12 months 6.Pregnancy or women of childbearing potential planning pregnancy 7.Patients with prior pacemaker implantation

Design outcomes

Primary

MeasureTime frame
Incidence of Atrial Fibrillation (AF);—

Secondary

MeasureTime frame
Post-pacing P-wave width;Hospitalization due to heart failure and arrhythmia;All-cause mortality;—

Countries

China

Contacts

Public ContactJie Fan

The First People's Hospital of Yunnan Province

fanj913@sina.com+86 136 0881 1433

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026